SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant momentum-driven rally fueled by high-profile partnerships with Google and Musks Tesla/SpaceX, as well as optimistic sentiment around its foundry business and domestic manufacturing potential. Community discussions are dominated by bullish targets, debates over institutional re-pricing, and warnings regarding potential volatility for those chasing the current run-up.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility driven by a massive AI-fueled surge in NAND memory demand and optimistic analyst price target hikes, while the community remains sharply divided between bulls chasing momentum and bears calling for a bubble burst. Conversations are dominated by intense speculation over potential stock splits, concerns regarding the sustainability of parabolic growth, and the broader impact of geopolitical tensions on the semiconductor sector.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing heightened volatility following unsubstantiated claims by Michael Burry that Anthropics growth is cannibalizing Palantirs market share, a narrative that has triggered a sell-off among momentum-driven traders. While the broader community remains fiercely divided between those who view this as a temporary, algorithm-fueled reaction to fear-based headlines and those who see the pullback as a necessary correction for an overextended valuation, many long-term bulls are focusing on the company's solid fundamentals and the technical distinction between Anthropic's model-layer services and Palantir's integrated operational platform.

Maulcoin

Maulcoin is trending as an active community of supporters rallies behind the project despite ongoing technical challenges with ticker and chart integration on social platforms. Investors are leaning into the project's 'dark side' branding and transparent communication, viewing the current stage as an early accumulation opportunity while the community works toward formal exchange listings.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing intense community volatility driven by a major earnings report and a newly announced $60 million at-the-market equity offering. Investors are sharply divided, with bulls pointing to the company's expanding role in the AI/photonics supply chain and robust bookings, while bears are aggressively shorting the stock, citing extreme valuations, insider selling, and significant dilution concerns.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is currently facing significant selling pressure as investors grapple with concerns regarding AI's potential to disrupt traditional enterprise software models. Despite strong long-term fundamentals and recent insider buying, the community remains divided, with many debating whether the current price represents a generational buying opportunity or a signal of deeper structural headwinds for SaaS companies.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as traders clash over conflicting signals regarding the semiconductor sector's resilience versus broader geopolitical instability. The community remains sharply divided, with bulls pointing to long-term memory demand and AI-driven growth to justify buying the dip, while bears increasingly warn of a potential "rug pull" driven by escalating tensions and technical weakness.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is seeing intense community debate as investors weigh concerns over subnet centralization and recent price volatility against its long-term potential as the "Bitcoin of AI." While some traders are liquidating positions due to broader market pressures and technical resistance, many long-term holders are actively utilizing dips to DCA and stake in the subnet ecosystem, viewing current price action as an accumulation phase.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake Inc. is currently facing heightened volatility as investors debate the impact of agentic AI advancements on its long-term software moat. While some market participants see the recent price drop as a value opportunity fueled by strong enterprise demand and revenue growth, others are actively betting against the stock, citing fears of market share erosion and the potential for AI to cannibalize traditional SaaS business models.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology is currently experiencing extreme volatility as traders speculate on a potential short squeeze, with community discussions heavily focused on comparing its recent price action to past "supernova" momentum runners. Market participants are debating the sustainability of these moves, frequently citing the stock's thin float and history of dramatic halts as they hunt for a breakout to triple-digit prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Take the Zacks Approach to Beat the Markets: LiveOne, Micron, Clorox in Focus

LVO, MU and CLX highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Hudson Bay Capital Management LP Sells 235,000 Shares of Intellia Therapeutics, Inc. $NTLA

Hudson Bay Capital Management LP lowered its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 50.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned...

Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus

ALLO, SBUX and AMGN highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Intellia Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Hold" by Brokerages

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) have received an average recommendation of "Hold" from the twenty-one analysts that are presently covering the stock, Marketbeat...

ARK Investment Management LLC Trims Stake in Intellia Therapeutics, Inc. $NTLA

ARK Investment Management LLC lessened its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 8.4% in the third quarter, according to the company in its most recent filing with...

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at JonesTrading

JonesTrading raised Intellia Therapeutics from a "hold" rating to a "buy" rating and set a $29.00 price objective for the company in a research report on Wednesday...

Intellia Therapeutics (NASDAQ:NTLA) Given New $48.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group cut their price objective on shares of Intellia Therapeutics from $54.00 to $48.00 and set a "buy" rating on the stock in a research report on Tuesday...

Leerink Partners Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Leerink Partners lifted their price target on shares of Intellia Therapeutics from $27.00 to $29.00 and gave the company an "outperform" rating in a research note on Tuesday...

Royal Bank Of Canada Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Royal Bank Of Canada lifted their price target on shares of Intellia Therapeutics from $9.00 to $15.00 and gave the company a "sector perform" rating in a research report on Tuesday...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.91	--	--	N/A
Q4 '25	-$0.94	-$0.83	11.81%	BEAT
Q3 '25	-$1.01	-$0.92	8.50%	BEAT
Q2 '25	-$1.02	-$0.98	3.70%	BEAT
Q1 '25	-$1.28	-$1.10	14.00%	BEAT

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest NTLA News

NTLAIntellia Therapeutics Inc